Clinical trial Recruiting at 1 site Observational

Registry for patients with endocrine tumors undergoing surgery

Official title: Registre Tumeurs Endocrine - Eurocrine

Run by Central Hospital, Nancy, France · NCT03410394 · Data updated 2026-11-12

This study is collecting information from patients with endocrine tumors who are having surgery to help improve treatment and care for these rare conditions across Europe.

Quick facts

Study typeObservational
SexAll
Enrollment3000 (estimated)
SponsorCentral Hospital, Nancy, France
Academic / other
Locations1 site (Vandœuvre-lès-Nancy)
StatusRecruiting
StartedJanuary 1, 2015
Main results expectedJanuary 1, 2030
Study endsJanuary 1, 2030
Registry record updatedOctober 22, 2026
Trial IDNCT03410394 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this registry are patients undergoing surgical procedures for endocrine tumors at the University Nancy Brabois Hospital.

Probably not a fit

Patients who are unable to provide informed consent or refuse to participate will not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects data on patients with endocrine tumors, including those affecting the thyroid, parathyroid, adrenal glands, endocrine pancreas, and digestive tube, who are undergoing surgical procedures. It is part of the Eurocrine Project, which aims to create a pan-European database to improve the understanding and treatment of these rare tumors. By recording and analyzing data at a European level, the project seeks to enhance clinical standards and reduce variations in practice across different clinics and countries. The ultimate goal is to decrease morbidity and mortality associated with these rare endocrine tumors through improved knowledge and practices.

Why it matters

Potential benefit: If successful, this registry could lead to improved diagnosis and treatment protocols for patients with rare endocrine tumors.

How similar studies have gone: Other studies have shown success in utilizing registries to improve outcomes for rare conditions, making this approach promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients who undergo surgical procedures for endocrine tumors at the University Nancy Brabois Hospital

Exclusion Criteria:

* unable to receive clear information
* refusal to sign the consent form

Where it's running

  • CHU Nancy
    Vandœuvre-lès-Nancy, France
    Recruiting

Study contacts

  • Principal investigator: laurent Brunaud — University of Lorraine
  • Study coordinator: laurent Brunaud, MD, PhD
  • Email: l.brunaud@chru-nancy.fr

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Methionine-Reduced Diet in Solid Tumors (early-phase)

    A small pilot study will test whether a methionine-reduced diet can change blood levels in adults with various solid tumors who are receiving standard cancer therapy.

    Recruiting Early Phase 1 University of California, Irvine · Orange, California · NCT07628634

  • Registry for aggressive pituitary tumors

    This study is collecting information on aggressive pituitary tumors to help doctors better understand and manage these cases for patients.

    Recruiting Hospices Civils de Lyon · Lyon · NCT05974696

  • Eating disorders in people with phenylketonuria

    This study looks at whether eating disorders and BMI issues are more common in people with phenylketonuria who are followed at a French hospital.

    Recruiting Central Hospital, Nancy, France · Nancy · NCT07698743

  • Piperacillin Prophylaxis in Major Liver and Pancreatic Surgery

    This study tests whether piperacillin/tazobactam given around surgery reliably reaches the right levels to help prevent infections in adults undergoing major liver or pancreatic surgery.

    Recruiting Central Hospital, Nancy, France · Vandœuvre-lès-Nancy, Lorraine and 1 other locations · NCT07558681

  • Real-time CLE imaging to speed and improve lung cancer diagnosis

    This project will try to see if using confocal laser endomicroscopy (CLE) during bronchoscopic biopsy can diagnose non-small cell lung cancer faster and with fewer or safer biopsies for people with suspected lung tumors.

    Recruiting Central Hospital, Nancy, France · Nancy · NCT07538947

  • Comparing the 2024 and 2017 McDonald rules for diagnosing multiple sclerosis

    This study will test whether the 2024 McDonald rules diagnose more people with MS at their first neurology visit than the 2017 rules for patients with a first clinical or radiological event suggestive of MS.

    Recruiting at 2 sites Central Hospital, Nancy, France · Ars-Laquenexy, Lorraine and 1 other locations · NCT07492667

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.